US Investor Challenges SAIF Partners-Backed Sinovac Biotech Take-Private Deal

healthcareA U.S. investor has challenged a management buyout proposal to take NASDAQ-listed Sinovac Biotech Ltd. private, saying the management and insiders made the bid one business day after the company received approval to produce a groundbreaking vaccine in China. In February, Chinese bio-pharmaceutical and vaccine firm Sinovac's chairman and CEO Yin Weidong and SAIF Partners […]


Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Read the original article: China Money Network